Logo image of CRGO

FREIGHTOS LTD (CRGO) Stock Fundamental Analysis

NASDAQ:CRGO - Nasdaq - KYG514051013 - Common Stock

4  +0.08 (+2.04%)

After market: 4.03 +0.03 (+0.75%)

Fundamental Rating

3

Overall CRGO gets a fundamental rating of 3 out of 10. We evaluated CRGO against 21 industry peers in the Air Freight & Logistics industry. While CRGO seems to be doing ok healthwise, there are quite some concerns on its profitability. While showing a medium growth rate, CRGO is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

In the past year CRGO has reported negative net income.
CRGO had a negative operating cash flow in the past year.
CRGO Yearly Net Income VS EBIT VS OCF VS FCFCRGO Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 -20M -40M -60M

1.2 Ratios

CRGO has a Return On Assets of -19.30%. This is in the lower half of the industry: CRGO underperforms 78.95% of its industry peers.
The Return On Equity of CRGO (-25.11%) is worse than 68.42% of its industry peers.
Industry RankSector Rank
ROA -19.3%
ROE -25.11%
ROIC N/A
ROA(3y)-54.67%
ROA(5y)N/A
ROE(3y)-83.92%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
CRGO Yearly ROA, ROE, ROICCRGO Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 -20 -40 -60 -80 -100

1.3 Margins

CRGO has a better Gross Margin (63.76%) than 89.47% of its industry peers.
CRGO's Gross Margin has improved in the last couple of years.
The Profit Margin and Operating Margin are not available for CRGO so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 63.76%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y5.31%
GM growth 5YN/A
CRGO Yearly Profit, Operating, Gross MarginsCRGO Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023 0 -100 -200 -300

More info and screens

5

2. Health

2.1 Basic Checks

CRGO does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, CRGO has more shares outstanding
CRGO has a better debt/assets ratio than last year.
CRGO Yearly Shares OutstandingCRGO Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 10M 20M 30M 40M
CRGO Yearly Total Debt VS Total AssetsCRGO Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 20M 40M 60M 80M

2.2 Solvency

CRGO has an Altman-Z score of 2.83. This is not the best score and indicates that CRGO is in the grey zone with still only limited risk for bankruptcy at the moment.
CRGO's Altman-Z score of 2.83 is in line compared to the rest of the industry. CRGO outperforms 57.89% of its industry peers.
CRGO has a Debt/Equity ratio of 0.01. This is a healthy value indicating a solid balance between debt and equity.
The Debt to Equity ratio of CRGO (0.01) is better than 84.21% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.01
Debt/FCF N/A
Altman-Z 2.83
ROIC/WACCN/A
WACC7.49%
CRGO Yearly LT Debt VS Equity VS FCFCRGO Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 2023 0 20M -20M 40M 60M

2.3 Liquidity

CRGO has a Current Ratio of 2.90. This indicates that CRGO is financially healthy and has no problem in meeting its short term obligations.
CRGO's Current ratio of 2.90 is amongst the best of the industry. CRGO outperforms 89.47% of its industry peers.
A Quick Ratio of 2.90 indicates that CRGO has no problem at all paying its short term obligations.
With an excellent Quick ratio value of 2.90, CRGO belongs to the best of the industry, outperforming 89.47% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 2.9
Quick Ratio 2.9
CRGO Yearly Current Assets VS Current LiabilitesCRGO Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 10M 20M 30M 40M 50M

More info and screens

6

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 81.91% over the past year.
Looking at the last year, CRGO shows a very negative growth in Revenue. The Revenue has decreased by -34.15% in the last year.
Measured over the past years, CRGO shows a very strong growth in Revenue. The Revenue has been growing by 33.57% on average per year.
EPS 1Y (TTM)81.91%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%60%
Revenue 1Y (TTM)-34.15%
Revenue growth 3Y33.57%
Revenue growth 5YN/A
Sales Q2Q%23.28%

3.2 Future

CRGO is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 14.87% yearly.
CRGO is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 23.38% yearly.
EPS Next Y29%
EPS Next 2Y14.89%
EPS Next 3Y13.44%
EPS Next 5Y14.87%
Revenue Next Year16.67%
Revenue Next 2Y22.1%
Revenue Next 3Y23.13%
Revenue Next 5Y23.38%

3.3 Evolution

Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
CRGO Yearly Revenue VS EstimatesCRGO Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 2028 10M 20M 30M 40M 50M
CRGO Yearly EPS VS EstimatesCRGO Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 2028 -0.5 -1 -1.5

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

CRGO reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year CRGO is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
CRGO Price Earnings VS Forward Price EarningsCRGO Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 -10 20

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
CRGO Per share dataCRGO EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 1

4.3 Compensation for Growth

A more expensive valuation may be justified as CRGO's earnings are expected to grow with 13.44% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y14.89%
EPS Next 3Y13.44%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for CRGO!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

FREIGHTOS LTD

NASDAQ:CRGO (1/21/2025, 8:00:00 PM)

After market: 4.03 +0.03 (+0.75%)

4

+0.08 (+2.04%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupTransportation
GICS IndustryAir Freight & Logistics
Earnings (Last)11-25 2024-11-25/bmo
Earnings (Next)N/A N/A
Inst Owners4.15%
Inst Owner Change-3.16%
Ins Owners7.89%
Ins Owner ChangeN/A
Market Cap197.44M
Analysts85
Price Target3.57 (-10.75%)
Short Float %0.33%
Short Ratio0.64
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)27.7%
Min EPS beat(2)-7.84%
Max EPS beat(2)63.24%
EPS beat(4)3
Avg EPS beat(4)29.11%
Min EPS beat(4)-7.84%
Max EPS beat(4)63.24%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)2
Avg Revenue beat(2)1.22%
Min Revenue beat(2)0.55%
Max Revenue beat(2)1.89%
Revenue beat(4)2
Avg Revenue beat(4)0.17%
Min Revenue beat(4)-1.17%
Max Revenue beat(4)1.89%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)3.57%
EPS NY rev (1m)0%
EPS NY rev (3m)21.11%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-4.69%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.46%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 8.79
P/FCF N/A
P/OCF N/A
P/B 3.1
P/tB 5.53
EV/EBITDA N/A
EPS(TTM)-0.34
EYN/A
EPS(NY)-0.35
Fwd EYN/A
FCF(TTM)-0.21
FCFYN/A
OCF(TTM)-0.21
OCFYN/A
SpS0.45
BVpS1.29
TBVpS0.72
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -19.3%
ROE -25.11%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 63.76%
FCFM N/A
ROA(3y)-54.67%
ROA(5y)N/A
ROE(3y)-83.92%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y5.31%
GM growth 5YN/A
F-Score3
Asset Turnover0.27
Health
Industry RankSector Rank
Debt/Equity 0.01
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 1.3%
Cap/Sales 0.17%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.9
Quick Ratio 2.9
Altman-Z 2.83
F-Score3
WACC7.49%
ROIC/WACCN/A
Cap/Depr(3y)9.87%
Cap/Depr(5y)N/A
Cap/Sales(3y)1.11%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)81.91%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%60%
EPS Next Y29%
EPS Next 2Y14.89%
EPS Next 3Y13.44%
EPS Next 5Y14.87%
Revenue 1Y (TTM)-34.15%
Revenue growth 3Y33.57%
Revenue growth 5YN/A
Sales Q2Q%23.28%
Revenue Next Year16.67%
Revenue Next 2Y22.1%
Revenue Next 3Y23.13%
Revenue Next 5Y23.38%
EBIT growth 1Y54.79%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year84.05%
EBIT Next 3Y24.55%
EBIT Next 5Y16.54%
FCF growth 1Y45.95%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y45.64%
OCF growth 3YN/A
OCF growth 5YN/A